Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 3 (RPL21P3)
- Target
- RPL21P3
- Molecular classification
- Other, Pseudogene
01
Overview
RPL21P3 is a processed pseudogene derived from the parent gene encoding ribosomal protein L21, a component of the large 60S ribosomal subunit in eukaryotes. Unlike its parent gene, RPL21P3 is classified as a pseudogene and is assumed to be non-functional, lacking protein-coding capability due to disabling mutations or truncation. Pseudogenes are sequences similar to known genes but do not produce functional products and are generally not considered therapeutic targets, biomarkers, or disease-relevant. There is no evidence of drugs, disease association, or biological function for RPL21P3; it is mainly catalogued in databases for genomic and evolutionary annotation.
- Other names
- bA189K21.4RPL21P3ribosomal protein L21 pseudogene 3
02
Mechanism of action
null
03
Biological functions
None established; typical for processed pseudogenes
04
Disease associations
None established; no evidence implicating RPL21P3 in disease
05
Interacting drugs
None reported; pseudogenes such as RPL21P3 do not interact with drugs
Beyond the preview
Go deeper on Ribosomal protein L21 pseudogene 3 (RPL21P3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 3 (RPL21P3).